Results 11 to 20 of about 105,856 (292)
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Explanations for variations in hospital expenditures among four large California counties
BMC Health Services Research, 2023 Objective To investigate competing explanations for why Medicare Fee for Service (FFS) and private sector payments lead to hospital cost variations in Californian counties.
Aimee J. Lansdale, Robert M. Kaplan
doaj +1 more source
The Milbank Quarterly, 2021 Policy Points Fixing the ACA requires real cost containment in addition to better subsidies. Private Medicare (Medicare Advantage) plans are uniquely empowered to control costs and deliver good care. Medicare Advantage plans should serve as the public option on the ACA Marketplace.
openaire +3 more sources
Health Services Research & Managerial Epidemiology, 2019 Medicare Advantage enrollment has seen tremendous growth over the past decade. However, we know comparatively little about the experience of beneficiaries in the program. Our knowledge of Medicare Advantage provider networks is particularly limited. This
Simon F. Haeder
doaj +1 more source
Journal of Medical Imaging and Radiation Oncology, EarlyView., 2023 Summary Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long‐term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir
Jeremy Khong +10 more
wiley +1 more source
How Successful Is Medicare Advantage? [PDF]
The Milbank Quarterly, 2014 ContextMedicare Part C, or Medicare Advantage (MA), now almost 30 years old, has generally been viewed as a policy disappointment. Enrollment has vacillated but has never come close to the penetration of managed care plans in the commercial insurance market or in Medicaid, and because of payment policy decisions and selection, the MA program is viewed ...
Joseph P, Newhouse, Thomas G, McGuire
openaire +2 more sources
Biosimilar Uptake in Medicare Advantage vs Traditional Medicare
JAMA Health Forum, 2023 This cross-sectional study uses Traditional Medicare and Medicare Advantage claims data to evaluate uptake of biosimilars relative to their reference products.
Kozlowski, Steven +6 more
openaire +2 more sources
Endocrinology, Diabetes & Metabolism, 2021 Aims To compare rates of use and adherence for newer versus older second‐line diabetes drug classes in commercially insured, Medicare Advantage and dual‐eligible (covered by both Medicare and Medicaid) patients.
James H Flory +3 more
doaj +1 more source
Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2022 Health insurance coverage options are complicated and often leave Medicare beneficiaries, families, advocates, and brokers confused. Medicare should make small changes to its existing “Compare Coverage Options” tool that would enhance the public’s ...
Lisa M. Grabert MPH
doaj +1 more source
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020 Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD).
Eric Jutkowitz +9 more
doaj +1 more source